Buscar en
Neurología (English Edition)
Toda la web
Inicio Neurología (English Edition) Cost minimisation analysis of fingolimod vs. natalizumab as a second line of tre...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Cost minimisation analysis of fingolimod vs. natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis
Análisis de minimización de costes entre fingolimod y natalizumab en segunda línea de tratamiento de esclerosis múltiple remitente-recurrente
C. Crespoa,b,
Corresponding author
carlos.crespo@oblikue.com

Corresponding author.
, G. Izquierdoc, A. García-Ruizd, M. Granelle, M. Brosab
a Departamento de Estadística, Universidad de Barcelona, Barcelona, Spain
b Oblikue Consulting, Barcelona, Spain
c Unidad de Esclerosis Múltiple, Hospital Universitario Virgen de la Macarena, Sevilla, Spain
d Departamento de Farmacología y Terapéutica Clínica, Facultad de Medicina, Universidad de Málaga, Málaga, Spain
e Novartis Farmacéutica, Barcelona, Spain
Read
3869
Times
was read the article
1104
Total PDF
2765
Total HTML
Share statistics
Article information
ISSN: 21735808
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 May 14 3 17
2024 April 45 11 56
2024 March 47 10 57
2024 February 35 4 39
2024 January 39 14 53
2023 December 28 19 47
2023 November 36 8 44
2023 October 32 15 47
2023 September 11 0 11
2023 August 14 4 18
2023 July 7 8 15
2023 June 19 9 28
2023 May 11 2 13
2023 April 13 2 15
2023 March 15 4 19
2023 February 9 1 10
2023 January 13 12 25
2022 December 20 5 25
2022 November 30 6 36
2022 October 20 9 29
2022 September 19 7 26
2022 August 15 9 24
2022 July 14 12 26
2022 June 14 6 20
2022 May 11 6 17
2022 April 33 9 42
2022 March 39 11 50
2022 February 42 6 48
2022 January 39 9 48
2021 December 27 14 41
2021 November 24 9 33
2021 October 74 8 82
2021 September 29 12 41
2021 August 25 8 33
2021 July 18 9 27
2021 June 17 6 23
2021 May 16 6 22
2021 April 45 9 54
2021 March 15 11 26
2021 February 18 6 24
2021 January 8 9 17
2020 December 12 6 18
2020 November 5 9 14
2020 October 14 5 19
2020 September 12 10 22
2020 August 13 7 20
2020 July 15 10 25
2020 June 6 6 12
2020 May 16 9 25
2020 April 7 1 8
2020 March 21 7 28
2020 February 22 6 28
2020 January 12 12 24
2019 December 22 13 35
2019 November 7 5 12
2019 October 18 7 25
2019 September 14 1 15
2019 August 27 6 33
2019 July 31 11 42
2019 June 28 17 45
2019 May 78 45 123
2019 April 27 28 55
2019 March 16 5 21
2019 February 13 10 23
2019 January 12 8 20
2018 December 7 8 15
2018 November 16 4 20
2018 October 25 21 46
2018 September 12 6 18
2018 August 5 1 6
2018 July 7 2 9
2018 June 5 5 10
2018 May 8 4 12
2018 April 1 6 7
2018 March 10 4 14
2018 February 12 7 19
2018 January 4 2 6
2017 December 15 2 17
2017 November 15 2 17
2017 October 11 2 13
2017 September 12 4 16
2017 August 20 5 25
2017 July 9 2 11
2017 June 21 9 30
2017 May 21 2 23
2017 April 16 2 18
2017 March 12 47 59
2017 February 12 2 14
2017 January 14 4 18
2016 December 29 9 38
2016 November 25 12 37
2016 October 46 7 53
2016 September 35 13 48
2016 August 13 6 19
2016 July 15 6 21
2016 June 28 12 40
2016 May 36 14 50
2016 April 35 17 52
2016 March 60 20 80
2016 February 45 20 65
2016 January 17 3 20
2015 December 23 6 29
2015 November 44 7 51
2015 October 27 9 36
2015 September 31 12 43
2015 August 12 12 24
2015 July 11 6 17
2015 June 14 4 18
2015 May 29 11 40
2015 April 29 13 42
2015 March 49 10 59
2015 February 34 10 44
2015 January 35 13 48
2014 December 35 12 47
2014 November 29 11 40
2014 October 30 18 48
2014 September 34 8 42
2014 August 42 8 50
2014 July 44 25 69
2014 June 34 17 51
2014 May 57 28 85
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos